CAMPs 2025 meeting highlights the use of CAMPs in all sites of care.

SmartTRAK reports the latest news and trends in cellular, acellular and matrix-like products (CAMPs) from the CAMPs 2025 Wound Care Summit held February 28 to March 2 in Fort Lauderdale, Florida. Hosted by the Journal of Wound Care (JWC), CAMPs 2025 showcased new clinical research, consensus guidelines and presentations supporting the use of CAMPs amid uncertainties in reimbursement for these products in the US Market for Skin Substitutes.

The subjects discussed in this downloadable SmartTRAK Perspective article include:

• The Broad Use of CAMPs
  • Sessions at CAMPs 2025 supported the broad use of CAMPs, including applications for diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) as well as those for limb salvage, acute care, tunneling wounds, Mohs surgery, trauma, burns and pressure ulcers (PrUs). SmartTRAK expects the use of CAMPs to ... (read more)
• LCD Discussions Taking Center Stage
  • With the implementation of the MAC LCDs delayed until April 13^th, a prevailing question among attendees at the conference was whether the LCDs would actually be implemented or further delayed. SmartTRAK spoke with clinicians and industry representatives to obtain their views on the LCDs and ... (read more)
• Market Disruption – 2025 Earnings Projections
  • For public companies providing skin substitutes to the market, uncertainty was a major theme in their 2025 guidance SmartTRAK  summarizes comments from companies that mentioned the LCD in their 2025 revenue projections ... (read more)

Although a significant amount of discussion with clinicians and industry focused on revising the reimbursement methodology for skin substitutes, companies are still moving forward with clinical studies. SmartTRAK is currently tracking 26 clinical trials for DFUs and VLUs, as mentioned earlier and ...

To find out more about news and trends from CAMPs 2025, just click the button below to download the complete market perspective article "LCD Uncertainty Bringing Disruption to CAMPs" by Susan Paquette, VP & General Manager, Wound.

---

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

SmartTRAK highlights four wound diagnostics companies utilizing artificial intelligence to watch in 2025.

Artificial intelligence (AI) is becoming increasingly ubiquitous in our personal and professional lives. AI is already being applied in healthcare in areas such as image analysis, personalized treatments and predictive care. Future potential applications include improved analysis of healthcare data, optimizing medication doses and enhancing patient education. The challenges of AI are also widely discussed, with ethical and legal concerns combined with a general worry that patient care could become dehumanized and distanced from healthcare professionals.

In this downloadable article, SmartTRAK identifies and discusses the following four diagnostic companies facilitating AI that should be watched in 2025:

• eKare
  • Wound assessment company eKare has been at the forefront of the conversation around AI in wound care. The core functionality of inSight, a 3D digital wound imaging system, includes AI aspects such as ... (read more)
• Mimosa Diagnostics
  • Canadian tissue oximetry company Mimosa Diagnostics primarily implements AI to enhance the usability of its Mimosa Pro device, which uses ... (read more)
• Spectral AI
  • Texas-based Spectral AI has undertaken significant fundraising over recent years. Over $150 million of Biomedical Advanced Research and Development Authority (BARDA) funding since 2013 has facilitated ... (read more)
• Swift Medical
  • Toronto-based Swift Medical saw a significant change in 2024. New leadership was announced in June as Dwayne Sansone and Stratos Davlos assumed the roles of CEO and CTO, respectively. The company received ... (read more)

The benefits of AI in wound care include accuracy and efficiency of wound characterization, remote monitoring, personalized care and increased accessibility to wound care ...

To find out more about how these companies are incorporating AI, just click the button below to download the complete market outlook article "Artificial Intelligence in Wound Diagnostics: Four Companies to Watch in 2025" by Kris Flinn, SmartTRAK General Manager, Wound.

SmartTRAK highlights the key trends in the US Compression Therapy market that will drive growth over the next few years.

In the US Market for Compression Devices, SmartTRAK projects revenues to reach a 5-year CAGR of +6.2%. In 2025, SmartTRAK expects mid-single-digit growth to continue and sees three key trends that will help drive growth over the next several years. These include:

SmartTRAK reports from the recent Wounds UK conference and discovers optimistic resilience in the face of challenging conditions.

SmartTRAK forecasts a challenging future for the UK Advanced Dressings Market. The UK has accessible outpatient reimbursement for dressings, has minimal higher-priced technologies such as Skin Substitutes and is the home market for two of the biggest global dressing companies. So why does this market show such low growth potential?

At the recent Wounds UK 2024 event, in an uncharacteristically sunny Harrogate, UK, SmartTRAK explored what is driving these variances and found a market in a period of change, as companies address commercial challenges with optimistic resilience, focusing on the following key topics:

• Pricing and Contracts
  • The fall had seen large tenders completed for The NHS Supply Chain and NHS Wales. These offered the first opportunity for significant price reviews for dressings in the hospital channel since COVID-19. Most companies that SmartTRAK spoke to anticipate prices to ... (read more)
• Wound Clinics
  • Private wound clinics continue to grow in the UK. The National Health Service (NHS) has been under significant pressure since COVID-19, and members of the public are increasingly open to ... (read more)
• Lack of Product Innovation
  • There was a noticeable lack of new innovative products at the conference, with leading companies primarily focusing on ... (read more)

Click the button below to download and read the complete "UK Market Growth Undermined by Advanced Dressings Challenges" perspective article by Kris Flinn, SmartTRAK Senior Analyst - Wound.

SmartTRAK looks at the market’s response to the recently finalized LCDs and the potential impact on the US Market for Skin Substitutes.

SmartTRAK examines the market dynamics, innovations and growth drivers for Negative Pressure Wound Therapy.

Since KCI (now  Solventum) introduced the wound V.A.C. to the market in 1996, traditional Negative Pressure Wound Therapy (tNPWT) has become the standard of care in hospitals for the treatment of hard-to-heal wounds .  While tNPWT has and will continue to experience low-single-digit revenue growth over the next several years, most of the growth in this space has been in single-use NPWT (sNPWT). According to SmartTRAK's US External Devices Market Overview, the US Market for sNPWT is forecasted to grow at a 5-year CAGR of roughly +13% . 

 

In this article, SmartTRAK provides an overview of the market dynamics impacting both the tNPWT and sNPWT segments of the US External Devices Market, including:

• Traditional Negative Pressure
  • Solventum and Smith+Nephew (SNN) are two key players in the tNPWT category, with a combined US market share of almost ... (read more)
    
• Single-Use Negative Pressure
  
  • Like the tNPWT market, both Solventum and SNN are key players in the sNPWT segment, together owning the vast majority of the market. sNPWT has been attracting a lot of interest from wound care companies, large and small, due to its sustained double-digit growth globally. SmartTRAK identifies and discusses three market strategies that are currently playing out in sNPWT as companies position themselves to capture share in this fast-growing segment. They are:
    
    • Large Dressing Companies Expanding into the sNPWT Adjacency
    • Start-Ups Focus on Pump-Free Products.
    • Growing the Market Through Expanded Use, Clinical Evidence ... (read more)

Click the button below to access and read the complete "Negative Pressure: Still Innovating, Growing and Expanding" article by Jay Merkel, SmartTRAK Sr Analyst, which highlights key large studies on the use of sNPWT in 2024, breaking them out into the studies that show benefits and the studies with moderate or no benefits.